Compare Stocks: SYBX, INMB, IMA, and BKHA

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BKHA Black Hawk Acquisition	$12.25 -0.9%	$11.96	$11.00 ▼ $13.10	$51.34M	0.04	9,127 shs	1,674 shs
IMA ImageneBio	$4.58	$5.29	$3.94 ▼ $9.10	$51.99M	0.7	16,346 shs	9,359 shs
INMB INmune Bio	$1.95 -0.5%	$2.12	$1.09 ▼ $2.60	$54.40M	0.93	337,401 shs	201,310 shs
SYBX Synlogic	$1.12 -2.6%	$1.14	$0.54 ▼ $1.87	$13.72M	0.5	67,213 shs	11,275 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BKHA Black Hawk Acquisition	-0.77%	+1.16%	+2.30%	-13.83%	+9.77%
IMA ImageneBio	0.00%	-5.92%	-10.20%	-21.44%	-43.80%
INMB INmune Bio	-0.51%	-2.50%	-15.22%	+14.71%	-5.80%
SYBX Synlogic	-2.61%	-2.61%	-8.20%	+59.77%	-33.33%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BKHA Black Hawk Acquisition	$12.25 -0.9%	$11.96	$11.00 ▼ $13.10	$51.34M	0.04	9,127 shs	1,674 shs
IMA ImageneBio	$4.58	$5.29	$3.94 ▼ $9.10	$51.99M	0.7	16,346 shs	9,359 shs
INMB INmune Bio	$1.95 -0.5%	$2.12	$1.09 ▼ $2.60	$54.40M	0.93	337,401 shs	201,310 shs
SYBX Synlogic	$1.12 -2.6%	$1.14	$0.54 ▼ $1.87	$13.72M	0.5	67,213 shs	11,275 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BKHA Black Hawk Acquisition	-0.77%	+1.16%	+2.30%	-13.83%	+9.77%
IMA ImageneBio	0.00%	-5.92%	-10.20%	-21.44%	-43.80%
INMB INmune Bio	-0.51%	-2.50%	-15.22%	+14.71%	-5.80%
SYBX Synlogic	-2.61%	-2.61%	-8.20%	+59.77%	-33.33%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BKHA Black Hawk Acquisition	1.00	Sell	N/A	N/A
IMA ImageneBio	2.25	Hold	$29.00	533.19% Upside
INMB INmune Bio	2.50	Moderate Buy	N/A	N/A
SYBX Synlogic	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest SYBX, INMB, IMA, and BKHA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/25/2026	IMA ImageneBio	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
8/21/2026	IMA ImageneBio	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$28.00
8/21/2026	IMA ImageneBio	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$28.00
8/19/2026	INMB INmune Bio	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/5/2026	INMB INmune Bio	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/20/2026	INMB INmune Bio	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/17/2026	BKHA Black Hawk Acquisition	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)

(Data available from 10/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BKHA Black Hawk Acquisition	N/A	N/A	N/A	N/A	N/A	N/A
IMA ImageneBio	$800K	64.98	N/A	N/A	$11.91 per share	0.38
INMB INmune Bio	$50K	1,082.25	N/A	N/A	$0.88 per share	2.22
SYBX Synlogic	$8K	1,714.86	N/A	N/A	$1.09 per share	1.03

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BKHA Black Hawk Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IMA ImageneBio	-$45.35M	-$4.58	N/A	N/A	N/A	N/A	-38.99%	-34.84%	N/A
INMB INmune Bio	-$45.93M	-$0.67	N/A	N/A	N/A	N/A	-82.87%	-62.23%	10/29/2026 (Estimated)
SYBX Synlogic	-$23.36M	-$0.06	N/A	N/A	N/A	N/A	-26.47%	-18.00%	11/11/2026 (Estimated)

Latest SYBX, INMB, IMA, and BKHA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
10/29/2026	Q3 2026	INMB INmune Bio	-$0.1467	N/A	N/A	N/A	$1.88 million	N/A
8/6/2026	Q2 2026	INMB INmune Bio	-$0.2067	-$0.05	+$0.1567	-$0.05	$1.16 million	N/A
8/5/2026	Q2 2026	IMA ImageneBio	-$0.90	-$0.63	+$0.27	-$0.63	N/A	N/A
7/15/2026	Q2 2026	BKHA Black Hawk Acquisition	N/A	$0.02	N/A	$0.02	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BKHA Black Hawk Acquisition	N/A	N/A	N/A	N/A	N/A
IMA ImageneBio	N/A	N/A	N/A	N/A	N/A
INMB INmune Bio	N/A	N/A	N/A	N/A	N/A
SYBX Synlogic	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BKHA Black Hawk Acquisition	N/A	N/A	N/A
IMA ImageneBio	N/A	21.47	21.47
INMB INmune Bio	N/A	4.04	4.04
SYBX Synlogic	N/A	2.65	2.65

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BKHA Black Hawk Acquisition	N/A
IMA ImageneBio	75.00%
INMB INmune Bio	12.72%
SYBX Synlogic	63.40%

Insider Ownership

Company	Insider Ownership
BKHA Black Hawk Acquisition	N/A
IMA ImageneBio	2.22%
INMB INmune Bio	21.40%
SYBX Synlogic	2.62%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BKHA Black Hawk Acquisition	N/A	4.15 million	N/A	N/A
IMA ImageneBio	18	11.35 million	11.10 million	Not Optionable
INMB INmune Bio	21	27.75 million	21.82 million	Optionable
SYBX Synlogic	80	12.25 million	11.39 million	No Data

SYBX, INMB, IMA, and BKHA Headlines

Recent News About These Companies

Synlogic (NASDAQ:SYBX) and Inovio Pharmaceuticals (NASDAQ:INO) Head to Head Contrast

September 21, 2026 | americanbankingnews.com

Reviewing Synlogic (NASDAQ:SYBX) and Oncobiologics (NASDAQ:OTLK)

September 16, 2026 | defenseworld.netD

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Varex Imaging Corporation (Nasdaq – VREX), Synlogic, Inc. (OTC – SYBX), Bowman Consulting Group Ltd. (Nasdaq – BWMN), Nathan's Famous, Inc. (Nasdaq – NATH)

August 28, 2026 | globenewswire.com

SYBX Stock Alert: Halper Sadeh LLC is Investigating Whether Synlogic, Inc. is Obtaining a Fair Price for its Shareholders

August 10, 2026 | tmcnet.com

Synlogic and Caldera Therapeutics announce merger and $278 million private placement

July 29, 2026 | msn.com

Synlogic and Caldera Therapeutics Announce Merger Agreement and Concurrent Private Placement

July 29, 2026 | aol.comA

Synlogic's Strategic Crossroads: A Company in Limbo

February 10, 2026 | aktiencheck.deA

Synlogic Challenges Nasdaq Delisting Notice

November 26, 2025 | tipranks.com

We Think Synlogic (NASDAQ:SYBX) Can Afford To Drive Business Growth

September 18, 2025 | uk.finance.yahoo.com

Synlogic, Inc. (SYBX) Latest Stock News & Headlines - Yahoo Finance

June 28, 2025 | finance.yahoo.com

Synlogic's executive sells shares worth $2,802

February 5, 2025 | msn.com

Synlogic Reports Q3 2024 Financial Outcomes

November 14, 2024 | markets.businessinsider.com

Synlogic, Inc.: Synlogic Reports Third Quarter 2024 Financial Results

November 13, 2024 | finanznachrichten.de

Synlogic Reports Third Quarter 2024 Financial Results

November 12, 2024 | globenewswire.com

Synlogic preps phenylketonuria drug for phase 3 after mid-stage win

November 6, 2024 | pharmaphorum.comP

Synlogic, Inc. (0A8U.L)

August 24, 2024 | nz.finance.yahoo.com

MIN.SG,0P0001I7V6,0 (MIN.SG)

August 16, 2024 | nz.finance.yahoo.com

Maintaining Hold on Synlogic Amid Strategic Reassessment and Financial Uncertainty

August 14, 2024 | markets.businessinsider.com

Synlogic, Inc.: Synlogic Reports Second Quarter 2024 Financial Results

August 8, 2024 | finanznachrichten.de

SYBX Stock Earnings: Synlogic Beats EPS for Q2 2024

August 8, 2024 | investorplace.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

SYBX, INMB, IMA, and BKHA Company Descriptions

Black Hawk Acquisition NASDAQ:BKHA

$12.24 -0.12 (-0.93%)

Closing price 09/30/2026 03:59 PM Eastern

Extended Trading

$12.34 +0.10 (+0.78%)

As of 09/30/2026 04:04 PM Eastern

Black Hawk Acquisition Corporation focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2023 and is based in Danville, California.

ImageneBio NASDAQ:IMA

$4.58 0.00 (0.00%)

Closing price 09/30/2026 04:00 PM Eastern

Extended Trading

$4.59 +0.01 (+0.22%)

As of 09/30/2026 07:30 PM Eastern

ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. Its lead product includes IMG-007, a non-depleting anti-OX40 mAb that has completed Phase 2a clinical trials for the treatment of atopic dermatitis and alopecia areata. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

INmune Bio NASDAQ:INMB

$1.95 -0.01 (-0.51%)

Closing price 09/30/2026 04:00 PM Eastern

Extended Trading

$2.01 +0.06 (+3.28%)

As of 09/30/2026 07:36 PM Eastern

INmune Bio, Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, a mucinous polyglucan on the surface of some epithelial cancer cells that appears to predict resistant to immunotherapy, including women with MUC4 expressing HER2+ breast cancer and other MUC4 resistant cancers. It also provides XPro1595 for the treatment of Alzheimer's disease and treatment resistant depression. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.

Synlogic NASDAQ:SYBX

$1.12 -0.03 (-2.61%)

As of 09/30/2026 03:43 PM Eastern

Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. for the research and pre-clinical development of a synthetic biotic medicine for the treatment of inflammatory bowel disease; and Ginkgo Bioworks, Inc. Synlogic, Inc. is based in Cambridge, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SYBX, INMB, IMA, and BKHA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SYBX, INMB, IMA, and BKHA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SYBX, INMB, IMA, and BKHA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SYBX, INMB, IMA, and BKHA Company Descriptions

Black Hawk Acquisition NASDAQ:BKHA

ImageneBio NASDAQ:IMA

INmune Bio NASDAQ:INMB

Synlogic NASDAQ:SYBX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SYBX, INMB, IMA, and BKHA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SYBX, INMB, IMA, and BKHA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SYBX, INMB, IMA, and BKHA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SYBX, INMB, IMA, and BKHA Company Descriptions

Black Hawk Acquisition NASDAQ:BKHA

ImageneBio NASDAQ:IMA

INmune Bio NASDAQ:INMB

Synlogic NASDAQ:SYBX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools